ArticleJournal for immunotherapy of cancer2024

Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 enhances antitumor efficacy and promotes immune-mediated antitumor responses.

Yijun Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.